Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer

Blok, E.J.; Engels, C.C.; Dekker-Ensink, G.; Kranenbarg, E.M.K.; Putter, H.; Smit, V.T.H.B.M.; ... ; Kuppen, P.J.K. (2018)

Article / Letter to editor

• Breast cancer
• Tumor infiltrating lymphocytes
• Endocrine therapy
• Exemestane
• Tamoxifen

• All authors: Blok, E.J.; Engels, C.C.; Dekker-Ensink, G.; Kranenbarg, E.M.K.; Putter, H.; Smit, V.T.H.B.M.; Liefers, G.J.; Morden, J.P.; Bliss, J.M.; Coombes, R.C.; Bartlett, J.M.S.; Kroep, J.R.; Velde, C.J.H. van de; Kuppen, P.J.K.
• Date: 2018-08-31
• Journal: Breast Cancer Research and Treatment
• Volume: 171
• Issue: 1
• Pages: 65 - 74
• DOI: doi:10.1007/s10549-018-4785-z
• Link: https://link.springer.com/content/pdf/10.1007/s10549-018-4785-z.pdf